Blairvacq, M. | IICIMED

Blairvacq, M.

Publications

P59

Eur. J. Med. Chem., 2008, 43(7), 1469-1477.

Novel 9-oxo-thiazolo[5,4-f]quinazoline-2-carbonitrile derivatives as dual cyclin-dependent kinase 1 (CDK1) / glycogen synthase kinase-3 (GSK-3) inhibitors: synthesis, biological evaluation and molecular modeling studies.

Logé, C. | Testard, A. | Thiery, V. | Lozach, O. | Blairvacq, M. | Robert, J-M. | Meijer, L. | Besson, T.

P53

Bioorg. Med. Chem. Lett. 2006, 16, 3419-3423.

Thiazolo[5,4-f]quinazolin-9-ones, inhibitors of glycogen synthase kinase-3.

Testard, A. | Logé, C. | Léger, B. | Robert, J-M. | Lozach, O. | Blairvacq, M. | Meijer, L. | Thiéry, V. | Besson, T.

Autres publications scientifiques

Brevets

Thèse